Explore evidence

6.7 %Cervical cancer screening uptake was 6.7% among HIV-positive females on HAART.

Nigeriacancer du col de l'utéruspublished 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 8 observations

57.4 %PD-L1 was positive in 57.4% of 183 cases of cervical cancer.

Nigeriacancer du col de l'utérusobserved 2012–2016published 2022PloS onePubMeddocument of 6 observations

93.5 %Among 400 female students in tertiary institutions in Imo State, 372 (93.5%) agreed that having multiple sexual partners was a risk factor for cervical cancer.

Nigeriacancer du col de l'utéruspublished 2021Journal of community healthPubMeddocument of 9 observations

70.5 %70.5% of the 105 surveyed Nigerian gynecologists endorsed the importance of the SOGON clinical practice guidelines for cervical cancer prevention.

Nigeriacancer du col de l'utéruspublished 2025JMIR cancerPubMeddocument of 8 observations

91.7 %91.7% of the women studied had never been screened for cervical cancer.

Nigeriacancer du col de l'utéruspublished 2021The Pan African medical journalPubMeddocument of 8 observations

19.4 %Among female undergraduates in a tertiary institution in south eastern Nigeria who had been screened for cervical cancer, 19.4% were in 500 level.

Nigeriacancer du col de l'utéruspublished 2021Journal of preventive medicine and hygienePubMeddocument of 11 observations

14.3 per_1000Cervical cancer mortality rate among adult women in Nigeria is 14.3 per 1000.

Nigeriacancer du col de l'utéruspublished 2025The Pan African medical journalPubMeddocument of 10 observations

Fewer than one-third of rural women in North Central Nigeria recognized intermenstrual or postcoital bleeding as symptoms of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 21 observations

4.9 %Post-intervention, risk factor knowledge improved from 4.9% to 7.2% in the control group.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 12 observations

Cervical cancer is the fourth most common cancer in women globally.

Nigeriacancer du col de l'utéruspublished 2023BMC women's healthPubMeddocument of 7 observations

62.5 %62.5% of patients received the 8 Gy × 3 fractions brachytherapy regimen.

Nigeriacancer du col de l'utéruspublished 2025BrachytherapyPubMeddocument of 8 observations

0.7 ng/mlThe mean squamous cell carcinoma antigen level in women with cervical cancer was 0.7 ± 0.5 ng/ml.

Nigeriacancer du col de l'utéruspublished 2025European journal of medical researchPubMeddocument of 8 observations

14,088 womenA total of 14,088 women were screened for cervical cancer between 2006 and 2016 at Jos University Teaching Hospital in Nigeria.

Nigeriacancer du col de l'utérusobserved 2006–2016published 2024Cancer causes & control : CCCPubMeddocument of 5 observations

25.5 %25.5% of the 231 women strongly agreed they were too young to have cervical cancer and hence there was no need for screening.

Nigeriacancer du col de l'utéruspublished 2021Cancer treatment and research communicationsPubMeddocument of 11 observations

84 %84% of women screened using pap smear had normal results.

Nigeriacancer du col de l'utéruspublished 2023BMC women's healthPubMeddocument of 5 observations

97 %Almost all participants (>97%) among 215 female secondary school students in Benin City, Nigeria had not heard of HPV, HPV vaccines, and cervical cancer.

Nigeriacancer du col de l'utérus · infection à HPVpublished 2020African health sciencesPubMeddocument of 3 observations

85.6 %Among female undergraduates in a tertiary institution in south eastern Nigeria, 85.6% were aware of cervical cancer as a disease.

Nigeriacancer du col de l'utéruspublished 2021Journal of preventive medicine and hygienePubMeddocument of 11 observations

66.6 %Among 400 female students in tertiary institutions in Imo State, 265 (66.6%) have heard of cervical screening.

Nigeriacancer du col de l'utéruspublished 2021Journal of community healthPubMeddocument of 9 observations

15.7 %15.7% of the respondents had provided money for cervical cancer screening.

Nigeriacancer du col de l'utérusobserved 2018published 2023PloS onePubMeddocument of 14 observations

70 %Using a cut-off value of 0.45, the specificity of squamous cell carcinoma antigen was 70%.

Nigeriacancer du col de l'utéruspublished 2025European journal of medical researchPubMeddocument of 8 observations

15.5 %15.5% of rural women in North Central Nigeria had fair/good knowledge of cervical cancer risk factors.

Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 21 observations

93.6 %93.6% of respondents were not aware of the Papanicolaou test (Pap smear test).

Nigeriacancer du col de l'utéruspublished 2021JCO global oncologyPubMeddocument of 7 observations

Cervical cancer is the most prevalent gynaecologic cancer in Nigeria.

Nigeriacancer du col de l'utéruspublished 2022Cancer reports (Hoboken, N.J.)PubMeddocument of 4 observations

350 cases350 out of 507 mothers living with HIV were aware of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2026BMC public healthPubMeddocument of 8 observations

22.4 %22.4% of rural women in North Central Nigeria cited absence of symptoms as a barrier to cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 21 observations